Piper Sandler raises Capricor Therapeutics price target to $25
Piper Sandler raised its price target on Capricor Therapeutics to $25.00 per share from $2.00,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.